Lineage Cell Therapeutics, Inc. (LCTX) Fundamentals

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, a oligodendrocyte progenitor cell therapy for acute spinal cord injuries and VAC2, a allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer. Its lead cell delivery clinical program is Renevia, an investigational medical device developed as an alternative for whole adipose tissue transfer procedures.
SHARE INFORMATION
Market Cap$ 217,472,953
Shares Outstanding149,981,347
Float127,301,065
Percent Float84.88%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 3,896,000
Latest Fiscal EPS$ -0.26
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions229
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months3,027,672
Institutional Holdings Percent53.3%
Institutional Sold Previous 3 Months13,586,774
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months415,450
Insider Holdings Percent8.5
Insider Sold Previous 3 Months20,793
Insider Shares Owned14,438,318
TRADING INFO
52 Week High$ 2.80
52 Week Low$ 1.10
52 Week High Change$ -40.08
21 Day Moving Average$ 1.5933
21 Day Extended Moving Average$ 1.5643
50 Day Moving Average$ 1.5462
50 Day Extended Moving Average$ 1.5348
200 Day Moving Average$ 1.6497
200 Day Extended Moving Average$ 1.6479
10 Day Average Volume506,240
20 Day Average Volume440,706
30 Day Average Volume414,022
50 Day Average Volume929,596
Alpha-0.009157
Beta1.5585
Standard Deviation0.172334
R20.204581
7 Day Price Change$ -0.10
7 Day Percent Change-6.45%
21 Day Price Change$ -0.17
21 Day Percent Change-10.49%
30 Day Price Change$ -0.14
30 Day Percent Change-8.81%
Month to Date Price Change$ -0.19
Month to Date Percent Change-11.59%
Quarter to Date Price Change$ -0.13
Quarter to Date Percent Change-8.23%
180 Day Price Change$ -0.01
180 Day Percent Change-0.68%
200 Day Price Change$ -0.06
200 Day Percent Change-3.97%
Year to Date Price Change$ -1.00
Year to Date Percent Change-40.82%

Lineage Cell Therapeutics, Inc. (LCTX) Key Ratios

PROFITABILITY
EBIT Margin-352.9%
EBITDA Margin-347.2%
Pre-Tax Profit Margin-2,336.6%
Profit Margin Count0.0%
Gross Margin87.8%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 12,952,000
Revenue Per Share$ 0.0864
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book9.80
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio3.00
Leverage Ratio1.50
Quick Ratio2.90
Long Term Debt To Capital0.02
VALUATION MEASURES
PE Ratio-4.90
Enterprise Value$ 179,610,565
Price to Sales16.7907
Price to Free Cash66.30
PE High Last 5 Years11.00
Price To Book3.00
Price To Cash Flow60.30
PE Low Last 5 Years-14.50
Price to Tangible Book9.80
MANAGEMENT EFFECTIVENESS
Receivables Turnover35.00
Invoice Turnover0.00
Assets Turnover0.10
Return Assets-39.74
Return on Equity-52.49
Return on Capital-47.67

Lineage Cell Therapeutics, Inc. (LCTX) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorOUM & Co. LLP
CEOBrian M. Culley
Emplyoees55
Last AuditUQ
CIK0000876343
IndustryBiotechnology
SectorHealthcare
NAICSBiological Product (except Diagnostic) Manufacturing(325414)
CONTACT INFO
Address2173 Salk Avenue
Suite 200
Carlsbad, CA 92008
Websitehttps://www.lineagecell.com
Facsimile-
Telephone+1 442 287-8990
EmailIR@lineagecell.com


Your Recent History
AMEX
LCTX
Lineage Ce..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.